1:19-cv-01732 - Cabaret Biotech Ltd v. Gilead Sciences Inc et al.

Detail

Case Number

1:19-cv-01732

Current Status

closed

Cause of Action

Declaratory Judgment

Related Case(s)

N/A

Court

Delaware District Court

Plaintiff(s)

Cabaret Biotech Ltd

NPE (Individual)

Defendant(s) SME

Gilead Sciences Inc

Kite Pharma Inc

Judge

Leonard P. Stark

Filing Date

2019-09-16

Termination Date

2020-12-23

Not a member? Sign up for free!
Dockets
Text
CIVIL DOCKET
UPDATED CIVIL DOCKET
Summons Issued with Magistrate Consent Notice attached as to Gilead Sciences, Inc. on 9/16/2019; Kite Pharma, Inc. on 9/16/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (kmd) (Entered: 09/16/2019)
COMPLAINT for a Declaratory Judgment that the `465 Patent is Not Invalid filed with Jury Demand against Gilead Sciences, Inc., Kite Pharma, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2731318.) - filed by Cabaret Biotech Ltd.. (Attachments: # 1 Exhibit 1, # 2 Civil Cover Sheet)(kmd) (Entered: 09/16/2019)
AMENDED COMPLAINT against All Defendants - filed by Cabaret Biotech Ltd.. (Attachments: # 1 Exhibit 1)(Keller, Karen) (Entered: 10/21/2019)
MOTION for Issuance of Letters Rogatory for the Production of Documents and Examination of Witnesses in Israel Pursuant to the Hague Convention - filed by Gilead Sciences, Inc., Kite Pharma, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit A)(Tigan, Jeremy) (Entered: 12/19/2019)
CLAIM Construction Chart by Cabaret Biotech Ltd.. (Attachments: # 1 Exhibit 1- Joint Claim Chart, # 2 Exhibit 2- U.S. Patent No. 7,741,465, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Exhibit 48, # 49 Exhibit 49)(Keller, Karen) (Entered: 04/01/2020)
Letter to The Honorable Leonard P. Stark from Karen E. Keller regarding technology tutorial. (Attachments: # 1 Tab 1 - Technology Tutorial)(Keller, Karen) (Entered: 05/15/2020)
Letter to The Honorable Leonard P. Stark from Karen E. Keller. (Attachments: # 1 Amended Claim Construction Chart, # 2 Exhibit 1 to Amended Claim Construction Chart)(Keller, Karen) (Entered: 05/27/2020)
Letter to The Honorable Leonard P. Stark from Jeremy A. Tigan regarding Defendants Technology Tutorial. (Attachments: # 1 Technology Tutorial)(Tigan, Jeremy) (Entered: 06/19/2020)
Joint APPENDIX re 68 Joint Claim Construction Brief (Volume 1 of 2) by Cabaret Biotech Ltd.. (Attachments: # 1 Exhibit A - Redacted License Agreement, # 2 Exhibit B - Declaration of William R. Strohl, Ph.D., # 3 Strohl - Exhibit 1, # 4 Strohl - Exhibit 2, # 5 Strohl - Exhibit 3, # 6 Strohl - Exhibit 4, # 7 Strohl - Exhibit 5, # 8 Strohl - Exhibit 6, # 9 Strohl - Exhibit 7, # 10 Strohl - Exhibit 8, # 11 Strohl - Exhibit 9, # 12 Strohl - Exhibit 10, # 13 Strohl - Exhibit 11, # 14 Strohl - Exhibit 12, # 15 Strohl - Exhibit 13, # 16 Strohl - Exhibit 14, # 17 Exhibit C - Declaration of Bryan A. Irving, Ph.D., # 18 Irving - Exhibit 1, # 19 Irving - Exhibit 2, # 20 Irving - Exhibit 3, # 21 Irving - Exhibit 4, # 22 Irving - Exhibit 5, # 23 Irving - Exhibit 6, # 24 Irving - Exhibit 7, # 25 Irving - Exhibit 8, # 26 Irving - Exhibit 9, # 27 Irving - Exhibit 10, # 28 Iriving - Exhibit 11, # 29 Irving - Exhibit 12, # 30 Irving - Exhibit 13, # 31 Irving - Exhibit 14, # 32 Irving - Exhibit 15, # 33 Irving - Exhibit 16, # 34 Iriving - Exhibit 17, # 35 Irving - Exhibit 18, # 36 Irving - Exhibit 19, # 37 Irving - Exhibit 20, # 38 Irving - Exhibit 21, # 39 Irving - Exhibit 22, # 40 Irving - Exhibit 23, # 41 Irving - Exhibit 24, # 42 Irving - Exhibit 25, # 43 Irving - Exhibit 26, # 44 Irving - Exhibit 27, # 45 Irving - Exhibit 28, # 46 Irving - Exhibit 29, # 47 Irving - Exhibit 30, # 48 Irving - Exhibit 31, # 49 Irving - Exhibit 32, # 50 Irving - Exhibit 33, # 51 Irving - Exhibit 34, # 52 Irving - Exhibit 35, # 53 Irving - Exhibit 36, # 54 Exhibit D - Supplemental Declaration of Bryan A. Irving, Ph.D., # 55 Irving - Exhibit 37, # 56 Irving - Exhibit 38, # 57 Exhibit E - Declaration of Richard A. Flavell, Ph.D., # 58 Flavell - Exhibit 1, # 59 Flavell - Exhibit 2, # 60 Flavell - Exhibit 3, # 61 Flavell - Exhibit 4, # 62 Flavell - Exhibit 5, # 63 Flavell - Exhibit 6, # 64 Flavell - Exhibit 7, # 65 Flavell - Exhibit 8, # 66 Flavell - Exhibit 9, # 67 Flavell - Exhibit 10, # 68 Flavell - Exhibit 11, # 69 Flavell - Exhibit 12)(Keller, Karen) Modified on 7/21/2020 (ntl). (Entered: 07/13/2020)
[SEALED] Joint APPENDIX re 68 Joint Claim Construction Brief (Volume 2 of 2) by Cabaret Biotech Ltd.. (Attachments: # 1 Exhibit F - Declaration of Dr. Jonathan Bramson, # 2 Bramson - Exhibit 1, # 3 Bramson - Exhibit 2, # 4 Bramson - Exhibit 3, # 5 Bramson - Exhibit 4, # 6 Bramson - Exhibit 5, # 7 Bramson - Exhibit 6, # 8 Bramson - Exhibit 7, # 9 Bramson - Exhibit 8, # 10 Bramson - Exhibit 9, # 11 Bramson - Exhibit 10, # 12 Bramson - Exhibit 11, # 13 Bramson - Exhibit 12, # 14 Bramson - Exhibit 13, # 15 Bramson - Exhibit 14, # 16 Bramson - Exhibit 15, # 17 Bramson - Exhibit 16, # 18 Bramson - Exhibit 17, # 19 Bramson - Exhibit 18, # 20 Bramson - Exhibit 19, # 21 Bramson - Exhibit 20, # 22 Bramson - Exhibit 21, # 23 Bramson - Exhibit 22, # 24 Bramson - Exhibit 23, # 25 Bramson - Exhibit 24, # 26 Bramson - Exhibit 25, # 27 Bramson - Exhibit 26, # 28 Bramson - Exhibit 27, # 29 Bramson - Exhibit 28, # 30 Bramson - Exhibit 29, # 31 Bramson - Exhibit 30, # 32 Bramson - Exhibit 31, # 33 Bramson - Exhibit 32, # 34 Bramson - Exhibit 33, # 35 Bramson - Exhibit 34, # 36 Bramson - Exhibit 35, # 37 Bramson - Exhibit 36, # 38 Bramson - Exhibit 37, # 39 Bramson - Exhibit 38, # 40 Bramson - Exhibit 39, # 41 Bramson - Exhibit 40, # 42 Bramson - Exhibit 41, # 43 Bramson - Exhibit 42, # 44 Bramson - Exhibit 43, # 45 Bramson - Exhibit 44, # 46 Bramson - Exhibit 45, # 47 Bramson - Exhibit 46, # 48 Exhibit G - Supplemental Declaration of Dr. Jonathan Bramson, # 49 Bramson - Exhibit 47-50)(Keller, Karen) (Entered: 07/13/2020)
REDACTED VERSION of 70 Appendix,,,,,, by Cabaret Biotech Ltd.. (Attachments: # 1 (Part 2 of 2))(Keller, Karen) (Entered: 07/20/2020)
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) (Entered: 09/16/2019)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,741,465 BL. (kmd) (Entered: 09/16/2019)
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cabaret Biotech Ltd.. (kmd) (Entered: 09/16/2019)
MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter (Count II of Complaint), MOTION to Strike 1 Complaint, (Jury Demand) - filed by Gilead Sciences, Inc., Kite Pharma, Inc.. (Blumenfeld, Jack) (Entered: 09/30/2019)
OPENING BRIEF in Support re 5 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter (Count II of Complaint) MOTION to Strike 1 Complaint, (Jury Demand) filed by Gilead Sciences, Inc., Kite Pharma, Inc..Answering Brief/Response due date per Local Rules is 10/15/2019. (Blumenfeld, Jack) (Entered: 09/30/2019)
ANSWER to 1 Complaint, , COUNTERCLAIM against Cabaret Biotech Ltd. by Kite Pharma, Inc., Gilead Sciences, Inc..(Blumenfeld, Jack) (Entered: 09/30/2019)
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Gilead Sciences, Inc. for Kite Pharma, Inc. filed by Gilead Sciences, Inc., Kite Pharma, Inc.. (Blumenfeld, Jack) (Entered: 09/30/2019)
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (Blumenfeld, Jack) (Entered: 09/30/2019)
MOTION for Pro Hac Vice Appearance of Attorney David B. Bassett, Vinita Ferrera, Emily R. Whelan, and Shirley X. Li Cantin - filed by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 10/07/2019)
MOTION for Pro Hac Vice Appearance of Attorney Eric A. Stone, Jennifer Gordon, Naz Wehrli and Tanya S. Manno - filed by Cabaret Biotech Ltd.. (Keller, Karen) (Entered: 10/14/2019)
REPLY BRIEF re 5 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter (Count II of Complaint) MOTION to Strike 1 Complaint, (Jury Demand) filed by Cabaret Biotech Ltd.. (Keller, Karen) (Entered: 10/15/2019)
ANSWER to 7 Answer to Complaint, Counterclaim by Cabaret Biotech Ltd..(Keller, Karen) (Entered: 10/21/2019)
ANSWER to Amended Complaint, re: 13 Amended Complaint , COUNTERCLAIM against Cabaret Biotech Ltd. by Kite Pharma, Inc., Gilead Sciences, Inc..(Blumenfeld, Jack) (Entered: 10/30/2019)
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding request to start the process leading to a scheduling order and conference. (Blumenfeld, Jack) (Main Document 16 replaced on 11/8/2019) (ntl). (Entered: 11/08/2019)
ANSWER to 15 Answer to Amended Complaint, Counterclaim by Cabaret Biotech Ltd..(Keller, Karen) (Entered: 11/20/2019)
Proposed MOTION for Scheduling Order - filed by Cabaret Biotech Ltd.. (Fry, David) (Entered: 11/22/2019)
NOTICE OF SERVICE of (1) Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s First Set of Interrogatories (Nos. 1-5) and (2) Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s First Set of Requests for Production (Nos. 1-26) filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Tigan, Jeremy) (Entered: 11/27/2019)
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 6/12/2020. Status Report due by 8/14/2020. A Markman Hearing is set for 6/22/2020 at 01:00 PM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 1/25/2021. A Final Pretrial Conference is set for 2/5/2021 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 5-day Jury Trial is set for 2/16/2021 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 12/6/19. (ntl) (Entered: 12/06/2019)
Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding request for bench trial. (Blumenfeld, Jack) (Entered: 12/10/2019)
NOTICE OF SERVICE of Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s Initial Disclosures filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Tigan, Jeremy) (Entered: 12/11/2019)
NOTICE OF SERVICE of 1. Plaintiff Cabaret Biotech Ltd.s Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1), 2. Cabaret Biotech Ltd.s First Set of Requests for the Production of Documents and Things to kite Pharma, Inc. and Gilead Sciences, Inc. (Nos. 1-23) filed by Cabaret Biotech Ltd..(Keller, Karen) (Entered: 12/11/2019)
STIPULATION TO EXTEND TIME to file a proposed protective order to December 18, 2019 - filed by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 12/17/2019)
PROPOSED ORDER Protective Order by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 12/19/2019)
NOTICE OF SERVICE of Plaintiffs Identification of Asserted Patents and File Histories filed by Cabaret Biotech Ltd..(Keller, Karen) (Entered: 12/19/2019)
ORDER granting 28 MOTION for Issuance of Letters Rogatory for the Production of Documents and Examination of Witnesses in Israel Pursuant to the Hague Convention - filed by Gilead Sciences, Inc., Kite Pharma, Inc. Signed by Judge Leonard P. Stark on 12/23/2019. (etg) (Entered: 12/23/2019)
NOTICE OF SERVICE of (1) Cabaret Biotech Ltd.s Objections and Responses to Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s First Set of Requests for Production (Nos. 1-26) (2) Cabaret Biotech Ltd.s Objections and Responses to Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s First Set of Interrogatories (Nos. 1-5) filed by Cabaret Biotech Ltd..(Keller, Karen) (Entered: 12/27/2019)
NOTICE OF SERVICE of Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Blumenfeld, Jack) (Entered: 01/06/2020)
NOTICE OF SERVICE of (1) Plaintiff Cabaret Biotech Ltd.s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery including Discovery of Electronically Stored Information filed by Cabaret Biotech Ltd..(Keller, Karen) (Entered: 01/06/2020)
NOTICE OF SERVICE of Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s Objections and Responses to Cabaret Biotech Ltd.s First Set of Requests for the Production of Documents and Things (Nos. 1-23) filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Tigan, Jeremy) (Entered: 01/10/2020)
NOTICE OF SERVICE of Defendants Initial Invalidity Contentions filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Blumenfeld, Jack) (Entered: 01/31/2020)
STIPULATION to Amend Scheduling Order by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 02/26/2020)
STIPULATION and [Proposed] Order Regarding Case Narrowing by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 03/09/2020)
NOTICE OF SERVICE of Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s Identification of Claim Terms for Construction filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Tigan, Jeremy) (Entered: 03/13/2020)
NOTICE requesting Clerk to remove Shirley X. Li Cantin as co-counsel. Reason for request: no longer with firm. (Tigan, Jeremy) (Entered: 03/17/2020)
NOTICE OF SERVICE of Claim Construction Disclosure filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Blumenfeld, Jack) (Entered: 03/20/2020)
MOTION for Pro Hac Vice Appearance of Attorney Jason H. Liss - filed by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 03/24/2020)
NOTICE OF SERVICE of Plaintiff Cabaret Biotech Ltd.s Responses to Defendants Initial Invalidity Contentions filed by Cabaret Biotech Ltd..(Keller, Karen) (Entered: 03/24/2020)
STIPULATION TO EXTEND TIME to File a Joint Claim Construction Chart to April 1, 2020 - filed by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 03/31/2020)
STIPULATION to Further Amend Scheduling Order (and Proposed Order) by Cabaret Biotech Ltd.. (Keller, Karen) (Entered: 04/09/2020)
SO ORDERED, re 46 Stipulation and Order -- Fact Discovery completed by 7/27/2020. Joint Claim Construction Brief due by 7/13/2020. Status Report due by 9/4/2020. A Markman Hearing is set for 8/3/2020 at 1:00 PM in Courtroom 6B. Signed by Judge Leonard P. Stark on 4/13/20. (ntl) (Entered: 04/15/2020)
NOTICE OF SERVICE of (1) Cabarets Opening Claim Construction Brief (2) Declaration of William R. Strohl, Ph.D. In Support of Cabarets Opening Claim Construction Brief for U.S. Patent No. 7,741,465 (3) Declaration of Bryan A. Irving, Ph.D. In Support of Cabarets Opening Claim Construction Brief for U.S. Patent No. 7,741,465 filed by Cabaret Biotech Ltd..(Keller, Karen) (Entered: 05/18/2020)
NOTICE OF SERVICE of Cabaret Biotech Ltd.s Supplemental Objections and Responses to Defendant Kite Pharma, Inc. and Gilead Sciences, Inc.s First Set of Request for Production (Nos. 1-26) filed by Cabaret Biotech Ltd..(Keller, Karen) (Entered: 05/20/2020)
NOTICE of Defendants Notice of Subpoenas to Baxter Healthcare Corporation by Gilead Sciences, Inc., Kite Pharma, Inc. (Tigan, Jeremy) (Entered: 06/11/2020)
NOTICE of Subpoenas to Dr. Patrick Hwu by Gilead Sciences, Inc., Kite Pharma, Inc. (Tigan, Jeremy) (Entered: 06/12/2020)
NOTICE of Subpoenas to Dr. Steven A. Rosenberg by Gilead Sciences, Inc., Kite Pharma, Inc. (Tigan, Jeremy) (Entered: 06/17/2020)
NOTICE of Subpoena to National Institutes of Health by Gilead Sciences, Inc., Kite Pharma, Inc. (Tigan, Jeremy) (Entered: 06/17/2020)
STATEMENT -- Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s Comments on Plaintiff Cabaret Biotechs Technology Tutorial (D.I. 48-1) by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 06/19/2020)
NOTICE OF SERVICE of Defendants Answering Claim Construction Brief filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Tigan, Jeremy) (Entered: 06/19/2020)
NOTICE OF SERVICE of (1) Cabaret Biotech Ltd.s First Set of Interrogatories to Kite Pharma, Inc. and Gilead Sciences, Inc. (Nos. 1-11) (2) Cabaret Biotech Ltd.s First Set of Requests for Admission to Kite Pharma, Inc. and Gilead Sciences, Inc. (Nos. 1-25) filed by Cabaret Biotech Ltd..(Keller, Karen) (Entered: 06/22/2020)
NOTICE OF SERVICE of Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s Second Set of Interrogatories (Nos. 6-15) filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Tigan, Jeremy) (Entered: 06/23/2020)
NOTICE of Subpoena to Dr. Bryan A. Irving by Gilead Sciences, Inc., Kite Pharma, Inc. (Tigan, Jeremy) (Entered: 06/24/2020)
NOTICE OF SERVICE of (1) Plaintiff Cabarets Notice of Deposition of Martin Silverstein (2) Plaintiff Cabarets Notice of Deposition of Aya Jakobovits (3) Plaintiff Cabarets Notice of Deposition of Arie Belldegrun (4) Plaintiff Cabarets Notice of Deposition of Scott Bernstein (5) Plaintiff Cabarets Notice of Deposition of Steve Ruchefsky (6) Plaintiff Cabarets Notice of Deposition of Adrian Bot (7) Plaintiff Cabarets Notice of Deposition of Margo Roberts (8) Plaintiff Cabarets Notice of Deposition of Kite and Gilead Pursuant to Fed, R. Civ. P. 30(b)(6) filed by Cabaret Biotech Ltd..(Keller, Karen) (Entered: 06/25/2020)
NOTICE to Take Deposition of Cabaret Biotech Ltd. on Date to be Mutually Negotiated by the Parties filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Tigan, Jeremy) (Entered: 06/25/2020)
NOTICE OF SERVICE of (1) Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s First Set of Requests for Admission to Plaintiff Cabaret Biotech, Ltd. (Nos. 1-25), (2) Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s Second Set of Requests for Production (Nos. 27-28), and (3) Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s Third Set of Interrogatories (Nos. 16-24) filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Tigan, Jeremy) (Entered: 06/26/2020)
STATEMENT re 57 Letter Plaintiffs Response to Defendants Technology Tutorial by Cabaret Biotech Ltd.. (Keller, Karen) (Entered: 07/02/2020)
NOTICE OF SERVICE of (1) Plaintiff Cabarets Amended Notice of Deposition of Steven B. Ruchefsky (2) Plaintiff Cabarets Amended Notice of Deposition of Martin B. Silverstein filed by Cabaret Biotech Ltd..(Keller, Karen) (Entered: 07/09/2020)
NOTICE OF SERVICE of Defendants Sur-Reply Claim Construction Brief filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Tigan, Jeremy) (Entered: 07/10/2020)
[SEALED] JOINT CLAIM CONSTRUCTION BRIEF filed by Cabaret Biotech Ltd.. (Keller, Karen) (Entered: 07/13/2020)
NOTICE OF SERVICE of Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s Amended Initial Disclosures filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Tigan, Jeremy) (Entered: 07/17/2020)
REDACTED VERSION of 68 Joint Claim Construction Brief by Cabaret Biotech Ltd.. (Keller, Karen) (Entered: 07/20/2020)
Letter to The Honorable Leonard P. Stark from Karen E. Keller regarding Public Version of D.I. 69 - re 69 Appendix,,,,,,,,. (Keller, Karen) (Entered: 07/20/2020)
NOTICE OF SERVICE of (1) Defendants Kite Pharma, Inc. and Gilead Sciences, Inc.s Responses and Objections to Plaintiff Cabaret Biotech, Ltd.s Rule 30(b)(6) Deposition Notice; (2) Kite Pharma, Inc. and Gilead Sciences, Inc.s Responses and Objections to Cabaret Biotech Ltd.s First Set of Interrogatories (Nos. 1-11); and (3) Kite Pharma, Inc. and Gilead Sciences, Inc.s Responses and Objections to Cabaret Biotech Ltd.s First Set of Requests for Admission to (Nos. 1-25) filed by Gilead Sciences, Inc., Kite Pharma, Inc..(Tigan, Jeremy) (Entered: 07/22/2020)
STIPULATION TO EXTEND TIME (and proposed order) to submit joint status report to September 9, 2020 - filed by Cabaret Biotech Ltd.. (Keller, Karen) (Entered: 08/18/2020)
STIPULATION TO EXTEND TIME for the parties to submit a joint status report to October 7, 2020 - filed by Cabaret Biotech Ltd.. (Hoeschen, Nathan) (Entered: 09/09/2020)
STIPULATION TO EXTEND TIME to Submit a Joint Status Report to October 28, 2020 - filed by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 10/06/2020)
ORDER re 79 STIPULATION TO EXTEND TIME to Submit a Joint Status Report to October 28, 2020 filed by Kite Pharma, Inc., Gilead Sciences, Inc. D.I. 5 is DENIED as moot (See D.I. 13). Signed by Judge Leonard P. Stark on 10/7/20. (ntl) (Entered: 10/07/2020)
STIPULATION TO EXTEND TIME to Submit a Joint Status Report to November 20, 2020 - filed by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 10/28/2020)
STIPULATION TO EXTEND TIME to Submit a Joint Status Report to December 11, 2020 - filed by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 11/20/2020)
STIPULATION TO EXTEND TIME to Submit a Joint Status Report to January 7, 2021 - filed by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 12/11/2020)
STIPULATION of Dismissal by Gilead Sciences, Inc., Kite Pharma, Inc.. (Tigan, Jeremy) (Entered: 12/18/2020)
Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 12/23/2020)
Timeline
filed_date
closed_date
Sep
Oct
Nov
Dec
2020
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2021
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2022
Feb
Mar
Apr
May
Jun
Jul
Aug
Patents In Case

Not a member? Sign up for free!